Article
Development and Validation of an Individualized Immune Prognostic Signature in HNSCC
2022-09-13
Abstract excerpt
Head and neck cancer is the seventh most common type of cancer worldwide, and the development of immunotherapy is conducive to the preservation of function and the improvement of prognosis. Based on immune gene database ImmPort and InnateDB, we investigated prognostic value of 546 head and necks squamous cell carcinoma samples from The Cancer Genome Atlas. We intersected of the two databases, selected specific mod...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 68fcbae1-a8a4-58d3-a77a-5fa3474680fd
- DOI
- 10.21203/rs.3.rs-2007096/v1
